Could a simple lock solution prevent dangerous line infections in kids?
NCT ID NCT04559334
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a 4% T-EDTA lock solution (KiteLock™) in 15 children aged 3 months to 18 years who have a central line for IV nutrition. The solution is placed into the line when not in use to prevent blood clots and infections. Researchers will track side effects, line blockages, breaks, and infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tetrasodium EDTA (KiteLock™ 4% Sterile Catheter Lock Solution)
What this could lead to
If it works, this could offer a safer way to keep central lines working and reduce infections in children who need long-term IV nutrition.
What could go wrong
This is a very small, early study (15 participants) that is currently suspended. The solution may cause side effects or fail to prevent clots or infections better than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION (CLABSI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens's Hospital Boston
Boston, Massachusetts, 02115, United States